Methylprednisolone acetate vs Tocilizumab
National NHS prescribing compared (Prescription Cost Analysis)
Methylprednisolone acetate was dispensed 68,423.0× as often as Tocilizumab in March 2026 — 68,423 items versus 1 in England.
68,423items
Methylprednisolone acetate · March 2026
NHSBSA Prescription Cost Analysis
1items
Tocilizumab · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Methylprednisolone acetate versus Tocilizumab: national items dispensed by month
▬ Methylprednisolone acetate · ╌ Tocilizumab
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Methylprednisolone acetate | Tocilizumab |
|---|---|---|
| Items, March 2026 | 68,423 | 1 |
| Items, last 12 months | 715,216 | 14 |
| Net ingredient cost, March 2026 | £338,729 | £228 |
See the full profile for Methylprednisolone acetate or Tocilizumab.